ME/CFS Research Foundation Logo

ME/CFS Biobank Austria

About

Status:
Ongoing
Principal investigator:
Country:
Austria
Study start:
2023-08-31
Completion (planned):
Not available
Last update:
2023-11-30

 

Research types:
Basic research
Research areas:
General
Interventions:
Not applicable
Priv. Sector Partner:
Not available
Sponsors:

Project description

The first Austrian ME/CFS Biobank has been under construction at the Medical University of Vienna since September 1, 2023, with support from an initial grant provided by the WE&ME Foundation. The primary goal of a biobank is to collect samples and patient data for scientific research in a standardized manner, following the same established protocols. In this particular case, the collection of samples is being coordinated with ME/CFS biobanks in the United Kingdom, Germany, and the Netherlands. The storage of samples and data will take place in dedicated facilities at the Medical University of Vienna.

The stated objective of the biobank project is to participate in large international collaborative projects. By utilizing biobank samples, it becomes possible to include a larger number of patients in research studies. Recently, a major joint EU project proposal was submitted to enhance ME/CFS research with the involvement of European biobanks. Ultimately, this will expedite research in the field of ME/CFS, as samples will be readily available for collaborative inquiries without the need for new sample collection. Furthermore, the researchers at the Medical University of Vienna hope that the availability of samples from the ME/CFS Biobank Austria will make Vienna an attractive hub for future therapeutic studies, as access to existing patient samples for comparative purposes will be possible.

(Description adapted from project website: see link above)

Patient cohort

Not available

Patients enrolled: Not available

Age group: Not available

Research areas (2)
Research types (1)
Research networks (0)
Working groups (1)
People (1)
Publications (0)
Organisations (1)